THRL logo

Target Healthcare REIT
THRL

Last Price

Financial Snapshot

gainify

Market Data

Market Cap
£605.35M
EV
£805.43M
Shares Outstanding
620.24M
Beta
0.49
Industry
REIT - Healthcare Facilities

Wall Street View

Analyst Rating
OUTPERFORM
Analyst Target Price
Number of Analysts
3
P/E 2026E
15.77x
P/Revenue 2026E
8.88x

Historical 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Forecasted 3Y Growth Rate

Revenue
EPS
Operating Cash Flow
Free Cash Flow

Margins & Returns

Gross Margin 2026E
-
Net Profit Margin 2026E
104.84%
ROE 2026E
-
ROCE 2025
8.68%

Dividends

DPS 2026E
£0.06
Payout Ratio 2026E
100.00%
Div. Yield 2026E
6.21%
DPS Last 3Y CAGR

Price Dynamic

Price

%

1M

3M

6M

1Y

3Y

5Y

Peers

gainify

About Target Healthcare REIT PLC

gainify
THRL logo

Target Healthcare REIT PLC

THRL

UK listed Target Healthcare REIT plc (THRL) is an externally managed FTSE 250 Real Estate Investment Trust which provides shareholders with an attractive level of income, together with the potential for capital and income growth, from investing in a diversified portfo...

Sector

Real Estate

Industry

REIT - Healthcare Facilities

CEO

MacKenzie, Kenneth

Employees

IPO Date

2013-03-07

Headquarters

Level 4 Dashwood House, 69 Old Broad Street, London, Greater London, EC2M 1QS, United Kingdom

📊 Stock Price & Performance

The last closing price of Target Healthcare REIT (THRL) is £0.97, reflecting a -0.51% change from the prior session. Last updated: December 31, 2025 at 7:30 AM Eastern Time

Review the recent THRL stock performance trends:Past 1 Month: Target Healthcare REIT (THRL) shares have +0.83%.Past 3 Months: The stock has +0.83%.Past 6 Months: THRL shares have -6.33%. Last updated: December 31, 2025 at 11:48 PM Eastern Time

Over the last year, Target Healthcare REIT (THRL) has established a 52-week price range between a high of £1.07 and a low of £0.78. This metric is essential for assessing the stock's annual volatility. Last updated: December 31, 2025 at 11:48 PM Eastern Time

Target Healthcare REIT (THRL) is considered a low volatility stock. It has a beta of 0.49, which means it typically moves 0.49 times as much as the broader market. Over the past 52 weeks, THRL has traded within a £0.78 – £1.07 range. Last updated: December 31, 2025 at 11:48 PM Eastern Time

Based on current THRL analyst forecasts and market assumptions, the consensus price target for Target Healthcare REIT (THRL) is £1.09 for 2027. Relative to the current price of £0.97, this implies a positive upside of +11.34%. Price targets reflect forward-looking estimates based on information available at the time and are inherently subject to change as underlying assumptions, company fundamentals, or market conditions evolve. Last updated: December 31, 2025 at 11:48 PM Eastern Time

A £1,000 investment in Target Healthcare REIT 5 years ago, when the stock was trading around £1.13, would be worth approximately £856.08 today, based solely on share price performance (excluding dividends). This represents a total return of -14.39% over the period, equivalent to a compound annual growth rate (CAGR) of -3.06%. Past performance reflects historical price movements only and does not imply future results. Last updated: December 31, 2025 at 11:48 PM Eastern Time

💰 Financial Metrics & Reports

The current Target Healthcare REIT (THRL) market capitalization is approximately £605.35M, based on its latest share price and shares outstanding. Market capitalization represents the total market value of a company's equity and is calculated by multiplying the current stock price by the number of shares outstanding. As a result, Target Healthcare REIT's market cap fluctuates with changes in its share price and share count. Last updated: December 31, 2025 at 11:48 PM Eastern Time

In the most recently reported quarter, Target Healthcare REIT (THRL) generated £18.83M in revenue, representing a +6.11% year over year change. Quarterly revenue results and expectations reflect underlying demand trends, pricing dynamics, product or service mix, seasonality, and broader macroeconomic conditions. Actual results may differ from consensus estimates as new information becomes available. Last updated: January 1, 2026 at 2:43 AM Eastern Time

In the most recently reported fiscal year, Target Healthcare REIT (THRL) generated net income of £60.85M, compared with £73.02M in the prior fiscal year, representing a -16.68% year over year change. For the upcoming fiscal year, analyst consensus currently estimates net income of £71.43M. Net income may be positive or negative and can fluctuate materially from year to year due to changes in operating performance, non-recurring or one-time items, accounting treatments, capital structure, and broader macroeconomic conditions. Last updated: January 1, 2026 at 2:43 AM Eastern Time

As of the most recent reporting period, the company's debt-to-equity ratio stands at 0.34x, calculated as total debt divided by total shareholders' equity. A lower debt-to-equity ratio generally indicates a more conservative capital structure with less reliance on external borrowing, while a higher ratio suggests greater financial leverage and potentially higher sensitivity to interest rates, refinancing conditions, and earnings volatility. The debt-to-equity ratio should be interpreted in the context of the company's industry, business model, cash flow stability, and balance sheet composition. Last updated: January 1, 2026 at 2:43 AM Eastern Time

Based on the latest available data, Target Healthcare REIT (THRL) is currently trading at a last twelve months (LTM) P/E ratio of 9.93x. The P/E ratio reflects how much investors are willing to pay today for a dollar of earnings and can vary meaningfully over time due to changes in profitability, growth expectations, margin outlook, and earnings volatility. Last updated: January 1, 2026 at 2:43 AM Eastern Time

📅 Earnings & Dividends

Target Healthcare REIT (THRL) is currently scheduled to report its next earnings results on March 11, 2026. Earnings dates are subject to change and may be updated by the company with limited notice. Investors typically monitor upcoming earnings releases closely, as they can result in increased volatility depending on reported results, forward guidance, and management commentary. Last updated: December 31, 2025 at 11:48 PM Eastern Time

In the most recently reported quarter, Target Healthcare REIT (THRL) revenue was £18.83M. Earnings per share (EPS) for the quarter were £0.02. Revenue and EPS surprises may be positive or negative and can influence near-term stock performance depending on expectations, forward guidance, and broader market and sector conditions. For a detailed history of analyst expectations versus reported results, view the full estimates vs. actuals track record here: 👉 Estimates vs. Actuals Last updated: January 1, 2026 at 2:43 AM Eastern Time

📈 Analyst Information

Analyst assessments of whether Target Healthcare REIT (THRL) consensus price target is overvalued or undervalued are generally expressed relative to consensus valuation frameworks and price targets, rather than as an absolute judgment.Current share price: £0.97Consensus price target: £1.09Implied return: +11.34% An implied return above current levels indicates that, on average, analysts view the stock as trading below their estimated fair value. Conversely, an implied return below current levels suggests the stock may be fully valued or priced above consensus expectations. This content is for informational purposes only and does not constitute investment advice. Last updated: January 1, 2026 at 2:43 AM Eastern Time

Based on the latest available analyst coverage, Target Healthcare REIT (THRL) currently carries a Outperform consensus rating. Analysts' average THRL price target is £1.09. Relative to the current share price of £0.97, this suggests a potential price change of approximately +11.34%. Analyst views are forward-looking estimates and should not be considered investment advice. Last updated: January 1, 2026 at 2:43 AM Eastern Time

Like other publicly traded stocks, Target Healthcare REIT (THRL) shares are bought and sold on stock exchanges such as LSE and other supported markets, depending on the listing. The most common way to buy shares is through an online brokerage account. To get started, you typically need to: Open an account with a licensed stock brokerComplete the broker's verification processFund your accountPlace a buy order for Target Healthcare REIT (THRL) shares Trading involves risk, and investors should consider their financial objectives and risk tolerance before investing.

ℹ️ Company Information

At the top right of this page, you'll see a star icon labeled Add to watchlist. Click it to add THRL to your watchlist.

Target Healthcare REIT trades under the ticker symbol THRL on the LSE stock exchange. The ticker THRL is used to identify the company's common stock across trading platforms, market data providers, and regulatory filings.

Target Healthcare REIT (THRL) operates in a highly competitive market with companies that often have different business models, geographic exposure, and end markets. While no two companies are identical, the following firms are generally considered the closest Target Healthcare REIT (THRL) stock peers based on overlapping products, services, and competitive dynamics:Primary Health Properties (PHP)Safestore Holdings (SAFE)Hammerson (HMSO)Land Securities Group (LAND) These peers may differ in size, business mix, financial profile, and strategic focus, but they are commonly referenced due to overlapping markets, customer segments, or competitive positioning relative to Target Healthcare REIT.

gainifypowered-by-sp
Socials
Send us an emailFollow us on XConnect with us on LinkedInFollow us on InstagramFollow us on ThreadsCheck us out on TrustpilotFollow us on YouTubeFind us on Google Maps

Market data is sourced from S&P Global Market Intelligence. All insights and analysis are developed by Gainify. Copyright © 2026, S&P Global Market Intelligence. All rights reserved.

View Data Providers

NEWSLETTER

Gainify provides tools and content designed to help users explore and understand the world of investing. All information available through our platform is for educational and informational use only. It is not intended as financial, investment or legal advice, and should not be treated as a recommendation or endorsement of any investment approach.
Our content is general in nature and does not account for your personal financial circumstances. Any investment decisions you make are your responsibility. We strongly recommend speaking with a licensed financial advisor or professional before acting on any information found on Gainify. Before using Gainify, please review our Terms of Service.

© 2026 Gainify. All rights reserved.